Correction to Lancet Gastroenterol Hepatol 2020; 5: 430–31

Ianiro G, Mullish BH, Kelley CR, et al. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. Lancet Gastroenterol Hepatol 2020; 5: 430–31—In this Comment, the declaration of interests statement should read: ”CRK has served as a clinical advisor, with no financial compensation, for OpenBiome since 2013; she is a local principal investigator for the PRISM-3 clinical trial, for which her institution receives some salary support for a research coordinator and compensation from Finch Therapeutics Group for each patient enrolled. HS reports personal fees from Danone, Enterome, Takeda, AbbVie, Roche, Amgen, Danone, BiomX, Ferring, BMS, Astellas, MSD, Novartis, Tillotts Pharma, and Biose, and grants from Biocodex, Danone, and BiomX, and is a co-founder of Exeliom Biosciences. ZK is an employee and shareholder of Finch Therapeutics and is an unpaid special advisor for OpenBiome. SCN reports grants from Ferring and personal fees from Takeda, AbbVie, Janssen, and Tillotts. MF reports personal fees from Finch Therapeutics Group, Rebiotix, Takeda, AbbVie, and Janssen. JRA reports personal fees from Finch Therapeutics and a non-financial relationship with OpenBiome as a scientific advisor. FZ reports grants from the non-profit China Microbiota Transplantation System (fmtBank) and a patent for GenFMTer for separating microbiota issued to FMT Medical. JK reports grants from Vedanta Biosciences and is an unpaid board member of the non-profit Netherlands Donor Feces Bank. SPC reports non-financial support from Janssen and personal fees from Shire, Ferring, Microbiotica, and Pfizer. AG reports personal fees for consultancy for Eisai S.r.l., 3PSolutions, Real Time Meeting, Fondazione Istituto Danone, Sinergie S.r.l. Board MRGE, and Sanofi S.p.A, personal fees for acting as a speaker for Takeda S.p.A, AbbVie, and Sandoz S.p.A, and personal fees for acting on advisory boards for VSL3 and Eisai. GI, BHM, LM, MS, HT, and GC declare no competing interests.” The sixth author should read “Siew C Ng”. These corrections have been made to the online version as of May 14, 2020.